Wide Range of resources on complex issues
We offer a wide range of resources on complex issues that impact all people with chronic conditions. Resources include member-specific services, frequent meetings and events, publications, and comments on rules and legislation.
NHC Launches Drug Pricing Blueprint Tracker
09/14/2018Since its release, many of the high-level priorities in the Department of Health and Human Services’ American Patients First drug pricing blueprint have been developed
Spotlight: Health Care Reform Action Team
09/12/2018By Katie Soisson, NHC Policy Associate The NHC’s Action Teams are an integral part of the organization’s policy-making process and serve as one of the
FDA’s Draft Guidance on Patient-Focused Drug Development: Collecting Comprehensive and Representative Input
09/11/2018The National Health Council (NHC) appreciates the opportunity to provide comments on the Food and Drug Administration’s (FDA’s) draft guidance on Patient-Focused Drug Development: Collecting
Going Back to School with the NHC’s New Educational Series: Increasing Patient-Community Capacity to Engage on Quality of Health Care
09/06/2018Today, the NHC debuted its first online educational series, Increasing Patient-Community Capacity to Engage on Quality of Health Care. The series, comprised of six modules,
Fighting the Opioid Crisis while Ensuring Access for Those Who Truly Need It
08/30/2018By: Marc Boutin, JD, Chief Executive Officer The National Health Council (NHC) acknowledges the complexity of the opioid crisis in the United States and commends
Making the Patient the Center of Comparative Effectiveness
08/20/2018In today’s New York Times, Aaron Carrol writes about the use of comparative effectiveness research to ensure new drugs are safe and effective when compared
Dr. Elisabeth Oehrlein Joins the National Health Council as Senior Director, Research and Programs
08/20/2018The National Health Council (NHC) has named Elisabeth Oehrlein, PhD, MS, as Senior Director, Research and Programs. In this newly created, leadership position, Dr. Oehrlein
Two Wrongs Don’t Make a Right
08/16/2018By Marc Boutin, JD, NHC Chief Executive Officer Last week, the Centers for Medicare and Medicaid Services (CMS) issued a new policy touted as a
Gottlieb Discusses Importance of Patient Engagement at NHC’s Dialogue on FDA Guidance
08/10/2018Today, FDA Commissioner, Scott Gottlieb, MD, spoke at our event, a dialogue on FDA’s first draft guidance on patient-focused drug development. Meeting participants engaged and